StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Trading Up 16.7 %
Shares of Sorrento Therapeutics stock opened at $0.01 on Thursday. Sorrento Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.42. The company has a 50-day moving average of $0.01 and a 200 day moving average of $0.04.
About Sorrento Therapeutics
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 5/20 – 5/24
- Investing in Travel Stocks Benefits
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- What Is WallStreetBets and What Stocks Are They Targeting?
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.